What's new in cancer monitoring?
Cancer monitoring by in vitro procedures is intimately linked to the identification of suitable tumor markers. Application of monoclonal antibodies (MAbs) not only led to the definition of new markers, but also to considerable progress in analytical methodology. In addition, monoclonal antibodies may be used for tumor targeting, thus opening the way for new diagnostic procedures (radioimmunolocalization) or therapeutic approaches.